advertisement
Journal of Ocular Pharmacology and Therapeutics 8
Showing records 1 to 8 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics67228 A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults with Ocular Hypertension or Primary Open-Angle Glaucoma
Myers JS
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 555-562
67584 Quantifying Glaucoma Medication Adherence: The Relationship Between Self-Report, Electronic Monitoring, and Pharmacy Refill
Kumar JB; Bosworth HB
Journal of Ocular Pharmacology and Therapeutics 2016; 0:
67228 A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults with Ocular Hypertension or Primary Open-Angle Glaucoma
Sall KN; DuBiner H
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 555-562
67584 Quantifying Glaucoma Medication Adherence: The Relationship Between Self-Report, Electronic Monitoring, and Pharmacy Refill
Sleath B; Woolson S
Journal of Ocular Pharmacology and Therapeutics 2016; 0:
67228 A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults with Ocular Hypertension or Primary Open-Angle Glaucoma
Slomowitz N; McVicar W
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 555-562
67584 Quantifying Glaucoma Medication Adherence: The Relationship Between Self-Report, Electronic Monitoring, and Pharmacy Refill
Olsen M; Danus S
Journal of Ocular Pharmacology and Therapeutics 2016; 0:
67228 A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults with Ocular Hypertension or Primary Open-Angle Glaucoma
Rich CC; Baumgartner RA
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 555-562
67584 Quantifying Glaucoma Medication Adherence: The Relationship Between Self-Report, Electronic Monitoring, and Pharmacy Refill
Muir KW
Journal of Ocular Pharmacology and Therapeutics 2016; 0: